In silico targeting of CYP19A1 and PTPN1 by Nigellidine: A network-based exploration of its antidiabetic pathway interactions. IJBB [Internet]. 2026 Apr. 17 [cited 2026 May 14];63(5):506-19. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/22700